Genetic Test Availability And Spending: Where Are We Now? Where Are We Going?
- 1 May 2018
- journal article
- research article
- Published by Health Affairs (Project Hope) in Health Affairs
- Vol. 37 (5), 710-716
- https://doi.org/10.1377/hlthaff.2017.1427
Abstract
Genetic testing and spending on that testing have grown rapidly since the mapping of the human genome in 2003. However, it is not widely known how many tests there are, how they are used, and how they are paid for. Little evidence from large data sets about their use has emerged. We shed light on the issue of genetic testing by providing an overview of the testing landscape. We examined test availability and spending for the full spectrum of genetic tests, using unique data sources on test availability and commercial payer spending for privately insured populations, focusing particularly on tests measuring multiple genes in the period 2014–17. We found that there were approximately 75,000 genetic tests on the market, with about ten new tests entering the market daily. Prenatal tests accounted for the highest percentage of spending on genetic tests, and spending on hereditary cancer tests accounted for the second-highest. Our results provide insights for those interested in assessing genetic testing markets, test usage, and health policy implications, including current debates over the most appropriate regulatory and payer coverage mechanisms.Keywords
This publication has 11 references indexed in Scilit:
- Evolving Payer Coverage Policies on Genomic Sequencing TestsJAMA, 2018
- Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into PracticeHealth Affairs, 2018
- Trends in utilization and costs of BRCA testing among women aged 18–64 years in the United States, 2003–2014Genetics in Medicine, 2018
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian CancerJournal of Clinical Oncology, 2017
- Creating a data resource: what will it take to build a medical information commons?Genome Medicine, 2017
- Utilization of genetic tests: analysis of gene-specific billing in Medicare claims dataGenetics in Medicine, 2017
- Payer coverage policies for multigene testsNature Biotechnology, 2017
- Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screeningGenetics in Medicine, 2017
- Genomic Sequencing: Assessing The Health Care System, Policy, And Big-Data ImplicationsHealth Affairs, 2014
- Growth of molecular diagnostics and genetic testing in the USA, 2008–2011: analysis and implicationsPersonalized Medicine, 2013